Welcome to the last episode of the Conversation: AIDS 2026 from Rio de Janeiro.

In partnership with Gilead Sciences, Plus Life is proud to bring powerful conversations with advocates, scientists, experts, community leaders, researchers, and more to the forefront of HIV prevention and treatment.

As we wind down another great conference, we ask our guests, “What gives us reason for hope?”

Today’s Guests:

• Michael Levy – SVP, Med Affairs And Reg Affairs, Patient Safety & Quality
• Ophelia Haanyama – Project manager på Posithiva Gruppen

And then Karl has a one on one chat with Moupali Das – Vice President, Clinical Development, HIV Prevention and Virology Pediatrics Head, HIV Prevention Gilead Sciences about what happens next.

We hope you’ve enjoyed The Conversation: #AIDS 2026 as much as we have loved bringing you the latest news, breakthroughs, and incredible conversations.

Join the movement to turn positive into a plus and follow us everywhere: @PlusLifeMedia